HLA-C locus alleles in patients with psoriatic arthritis (PsA)

被引:66
作者
Gladman, DD
Cheung, C
Ng, CM
Wade, JA
机构
[1] Toronto Hosp, Western Div, Ctr Prognosis Studies Rheumat Dis, Psoriat Arthrit Program, Toronto, ON M5T 2S8, Canada
[2] Toronto Hosp, Reg HLA Lab, Toronto, ON M5T 2S8, Canada
[3] Toronto Hosp, Res Inst, Toronto, ON M5T 2S8, Canada
基金
英国医学研究理事会;
关键词
psoriatic arthritis; HLA-C;
D O I
10.1016/S0198-8859(98)00123-2
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The aim of this investigation was to compare the frequency of alleles at the HLA-C locus in patients with psoriatic arthritis to that in the disease free population and to relate the HLA genes to disease phenotype in psoriatic arthritis (PsA). Ninety-four consecutive patients seen in the (PsA) clinic between April and July 1996 and 100 disease-free controls had HLA typing performed by both serologic and molecular techniques. Patients' disease was assessed according to a standard protocol. Fisher's exact test was used to compare the frequency of HLA alleles in the patients and controls. HLA-C determined by PCR-SSP decreased the frequency of non-identified, that is, "blank" (or null) alleles to 6% in patients and controls. HLA-Cw*0602 was present in 32 patients and 18 controls: allele frequency of 17% in the patients Versus 9% in the controls (p < 0.01). Amongst patients with psoriatic arthritis, those who carried the HLA-Cw*0602 allele had a significantly earlier mean age of onset of their psoriasis (P = 0.003). This study confirms that molecular DNA techniques improve detection of C-locus alleles. The HLA-Cw*0602 is increased amongst patients with psoriatic arthritis compared to controls. The HLA-Cw*0602 is associated with an earlier age of onset of psoriwis. Human Immunology 60, 259-261 (1999). (C) American Society for Histocompatibility and Immunogenetics, 1999 Published by Elsevier Science Inc.
引用
收藏
页码:259 / 261
页数:3
相关论文
共 10 条
[1]  
Bunce M., 1997, Tissue Antigens, V50, P100, DOI 10.1111/j.1399-0039.1997.tb02847.x
[2]   GENETICS AND HLA ANTIGENS [J].
EASTMOND, CJ .
BAILLIERES CLINICAL RHEUMATOLOGY, 1994, 8 (02) :263-276
[3]  
Enerback C, 1997, ACTA DERM-VENEREOL, V77, P273
[4]  
GLADMAN DD, 1987, Q J MED, V62, P127
[5]  
GLADMAN DD, 1986, J RHEUMATOL, V13, P586
[6]   HLA-CW*0602 is a susceptibility factor in type I psoriasis, and evidence Ala-73 is increased in male type I psoriatics [J].
Mallon, E ;
Bunce, M ;
Wojnarowska, F ;
Welsh, K .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1997, 109 (02) :183-186
[7]   Comparison of typing results by serology and polymerase chain reaction with sequence-specific primers for HLA-Cw in 650 individuals [J].
Mytilineos, J ;
Christ, U ;
Lempert, M .
TISSUE ANTIGENS, 1997, 50 (04) :395-400
[8]   HLA-DR TYPING BY PCR AMPLIFICATION WITH SEQUENCE-SPECIFIC PRIMERS (PCR-SSP) IN 2 HOURS - AN ALTERNATIVE TO SEROLOGICAL DR TYPING IN CLINICAL-PRACTICE INCLUDING DONOR-RECIPIENT MATCHING IN CADAVERIC TRANSPLANTATION [J].
OLERUP, O ;
ZETTERQUIST, H .
TISSUE ANTIGENS, 1992, 39 (05) :225-235
[9]  
TOMLINSON IPM, 1995, TIG, V11, P492
[10]   DISTINCTIVE POLYMORPHISM AT THE HLA-C LOCUS - IMPLICATIONS FOR THE EXPRESSION OF HLA-C [J].
ZEMMOUR, J ;
PARHAM, P .
JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 176 (04) :937-950